CAJ | 학술논문

介入治疗后再狭窄是影响经皮腔内血管成形术治疗疗效的主要原因,也是近年来研究的热点及难点之一.内皮祖细胞是一类能增生并分化成血管内皮细胞的前体细胞,参与体内内皮损伤后的修复和血管再生,有望在血管介入治疗后再狭窄的防治中起重要的作用,本文对内皮祖细胞的研究概况及其近年来在防治介入治疗后再狭窄的研究进展进行综述.
개입치료후재협착시영향경피강내혈관성형술치료료효적주요원인,야시근년래연구적열점급난점지일.내피조세포시일류능증생병분화성혈관내피세포적전체세포,삼여체내내피손상후적수복화혈관재생,유망재혈관개입치료후재협착적방치중기중요적작용,본문대내피조세포적연구개황급기근년래재방치개입치료후재협착적연구진전진행종술.
Restenosis after interventional treatment is the major factor infheneing the result of percutaneous transluminal angioplasty, and it is a hot and difficult research in recent years. Endothelial progenitor cells are a class of proliferation and able to differentiate into vascular endothelial precursor cells, and take part in the repair and angiogenesis after endothelial injury-intimate. It is expected to play an important role in the prevention of vascular restenosis after interventional treatment. In this article, we reviewed the endothelial progenitor cell research overview and advances of prevention of restenosis after interventional therapy in recent years.